Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 7/20 | 1.00 |
| ▸ | HMGCR | P04035 | 6/20 | 1.00 |
| ▸ | LMNA | P02545 | 5/20 | 1.00 |
| ▸ | TSHR | P16473 | 5/20 | 1.00 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 1.00 |
| ▸ | HIF1A | Q16665 | 4/20 | 1.00 |
| ▸ | MEN1 | O00255 | 3/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 3/20 | 1.00 |
| ▸ | ABCB11 | O95342 | 3/20 | 1.00 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 1.00 |
| ▸ | CYP1A2 | P05177 | 2/20 | 1.00 |
| ▸ | MAPK1 | P28482 | 1/20 | 1.00 |
| ▸ | MTOR | P42345 | 1/20 | 1.00 |
| ▸ | HTT | P42858 | 1/20 | 1.00 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 1.00 |
| ▸ | GMNN | O75496 | 1/20 | 1.00 |
| ▸ | TP53 | P04637 | 1/20 | 1.00 |
| ▸ | CYP2D6 | P10635 | 1/20 | 1.00 |
| ▸ | NFKB1 | P19838 | 1/20 | 1.00 |
| ▸ | BLM | P54132 | 1/20 | 1.00 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Mevastatin SCHEMBL14545225 | 1.00 | CYP3A4 (1.00) | CYP3A4HMGCRLMNATSHRSMN1; SMN2 | |
| Mevastatin SCHEMBL15976637 | 1.00 | CYP3A4 (1.00) | CYP3A4HMGCRLMNATSHRSMN1; SMN2 | |
| Mevastatin SCHEMBL14307237 | 1.00 | CYP3A4 (1.00) | CYP3A4HMGCRLMNATSHRSMN1; SMN2 | |
| Mevastatin SCHEMBL4544785 | 1.00 | CYP3A4 (1.00) | CYP3A4HMGCRLMNATSHRSMN1; SMN2 | |
| Mevastatin SCHEMBL23936978 | 1.00 | CYP3A4 (1.00) | CYP3A4HMGCRLMNATSHRSMN1; SMN2 | |
| Mevastatin SCHEMBL7721400 | 1.00 | CYP3A4 (1.00) | CYP3A4HMGCRLMNATSHRSMN1; SMN2 | |
| Mevastatin SCHEMBL23636208 | 1.00 | CYP3A4 (1.00) | CYP3A4HMGCRLMNATSHRSMN1; SMN2 | |
| Mevastatin SCHEMBL21340588 | 1.00 | CYP3A4 (1.00) | CYP3A4HMGCRLMNATSHRSMN1; SMN2 | |
| Mevastatin SCHEMBL21340571 | 1.00 | CYP3A4 (1.00) | CYP3A4HMGCRLMNATSHRSMN1; SMN2 | |
| Mevastatin SCHEMBL21340628 | 1.00 | CYP3A4 (1.00) | CYP3A4HMGCRLMNATSHRSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 29588 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4051153-B1 | COMPACT LASER-STEERING END EFFECTOR | HARVARD COLLEGE (US) | 2026-05-27 | — | — | EP | claimed |
| WO-2026104329-A1 | SYSTEM AND METHOD FOR DETECTING OPTICAL SIGNALS OF A TEST OBJECT THAT IS MOVED RELATIVE TO A TARGET | Deutsches Zentrum für Luft- und Raumfahrt e.V. (DE) | 2026-05-21 | — | — | WO | claimed |
| EP-3729084-B1 | IMMUNE CELL ORGANOID CO-CULTURES | KONINKLIJKE NEDERLANDSE AKADEMIE VAN WETENSCHAPPEN (NL) | 2026-05-20 | — | — | EP | claimed |
| EP-4745160-A1 | METHOD FOR TREATING OR PREVENTING CHOLESTEROL-RELATED DISEASES USING PCSK9 INHIBITOR | Salubris (Chengdu) Biotech Co., Ltd. (CN) | 2026-05-20 | — | — | EP | claimed |
| EP-4093327-B1 | ENDOPROSTHESES WITH INTERLOCKING STENTS HAVING VARYING STIFFNESS | GORE & ASS (US) | 2026-05-06 | — | — | EP | claimed |
| EP-4255391-B1 | LUMINOL FOR USE IN THE TREATMENT OF SEQUELAE OF A SARS-COV-2 INFECTION | METRIOPHARM AG (CH) | 2026-05-06 | — | — | EP | claimed |
| EP-3681297-B1 | PROCESS OF MAKING CURED MEAT PRODUCTS BASED ON NON-MINCED COOKED MEAT AND NON-MINCED COOKED MEAT MADE WITH SUCH PROCESS | ROVAGNATI S P A (IT) | 2026-05-06 | — | — | EP | claimed |
| EP-4731433-A1 | SYSTEM AND METHOD FOR PRODUCING PAPER STICKS | Setter Holding GmbH (DE) | 2026-04-29 | — | — | EP | claimed |
| EP-4248976-B1 | ANTIGEN BINDING PROTEINS TO PROPROTEIN CONVERTASE SUBTILISIN KEXIN TYPE 9 (PCSK9) | AMGEN INC (US) | 2026-04-22 | — | — | EP | claimed |
| EP-3971084-B1 | AÉRONEF MULTI-ROTOR PLIABLE | SZ DJI TECHNOLOGY CO LTD (CN) | 2026-04-22 | — | — | EP | claimed |
| US-5130333-A | Mevastatin, lovastatin, pravastatin or velostatin for diabetes and cholesterol reduction | E. R. SQUIBB & SONS, INC. (US) | 1992-07-14 | — | — | US | claimed |
| EP-0482498-A2 | Method for preventing diabetic complications employing a cholesterol lowering drug alone or in combination with an ace inhibitor | E.R. SQUIBB & SONS, INC. (US) | 1992-04-29 | — | — | EP | claimed |
| EP-0461548-A2 | Method for preventing a second heart attack employing and HMG CoA reductase inhibitor | E.R. SQUIBB & SONS, INC. (US) | 1991-12-18 | — | — | EP | claimed |
| EP-0457514-A1 | Method for preventing, stabilizing or causing regression of atherosclerosis employing a combination of a cholesterol lowering drug and an ace inhibitor | E.R. SQUIBB & SONS, INC. (US) | 1991-11-21 | — | — | EP | claimed |
| EP-0429306-A2 | Data compaction system | International Business Machines Corporation (US) | 1991-05-29 | — | — | EP | claimed |
| EP-0401705-A2 | Use of an HMG CoA reductase inhibitor and/or a squalene synthetase inhibitor for treating peripheral atherosclerotic disease | E.R. Squibb & Sons, Inc. (US) | 1990-12-12 | — | — | EP | claimed |
| US-4950775-A | REACTING ALDEHYDE WITH KETOPHOSPHONATE SYNTHON | UNIVERSITY OF CALIFORNIA (US) | 1990-08-21 | — | — | US | claimed |
| EP-0373931-A2 | Monoesters of arylacetic acid, their production and use | SHIONOGI SEIYAKU KABUSHIKI KAISHA trading under the name of SHIONOGI & CO. LTD. (JP) | 1990-06-20 | — | — | EP | claimed |
| EP-0373507-A1 | Combination of an HMG CoA reductase inhibitor and other type of serum cholesterol reducing agent and method for lowering serum cholesterol using such combination | E.R. SQUIBB & SONS, INC. (US) | 1990-06-20 | — | — | EP | claimed |
| EP-0010299-A1 | Pharmaceutical composition useful for the treatment of hypercholesteremia | MERCK & CO. INC. (US) | 1980-04-30 | — | — | EP | claimed |